Archives: Agenda
Psychedelic Compounds in Clinical Trials: The Risks and Benefits of Video Recording Subjects
• Patient consent
• Patient safety and clinician accountability
• Data privacy, HIPAA, 21 CFR Part 11 and related guidelines and regulations
• Bias
• Education and research implications
Lunch and networking
Ensuring Adequate Sponsor Oversight of Clinical Trials When Outsourced to Clinical Contract Research Organisations
This presentation will highlight.
- Ensuring that KPIs are informative and meaningful.
- Assessing overall project risk and appropriate surveillance tactics
- Consolidating your overall management strategy that can be coordinated with CRO SOPs
- Providing documentation of Sponsor oversight activities throughout the study
Setting up Global Clinical Trials, with a focus on Asia Pacific
• Strategies for Country and Site Selection
• Optimizing cost and time
• Large and small company perspectives
• Leveraging global trial footprint to accelerate clinical development
• The evolution of Clinical Development in AsiaPacific
• How different notified bodies and their regulations present challenges to our clinical execution strategies
Afternoon Break and Apple Prize Draw
Chair’s Opening Remarks
Afternoon Break and Apple Prize Draw
PANEL: Exploring the transition of Innovation & technological advancements in clinical trials
- Are we making the most of Technology & Innovation in the Clinical Trial space?
- How are these tools being utilized efficiently?
- The importance of exploring ethical considerations.
- Examining the relationship between innovation, creativity, and regulations
- What’s next?
Clinical Trials: Usage of CROs
|